NFA
HSTO

Nationwide Fund Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Nationwide Fund Advisors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-73
Closed -$80K – 2469
2017
Q3 		$80K Hold
73
– – ﹤0.01% 2972
2017
Q2 		$84K Sell
73
-285
-80% -$347K ﹤0.01% 2966
2017
Q1 		$413K Buy
+358
New +$346K ﹤0.01% 2253
2014
Q2 		– Sell
-24
Closed -$39K – 3402
2014
Q1 		$39K Buy
24
+1
+4% +$2.09K ﹤0.01% 2873
2013
Q4 		$29K Buy
23
+16
+229% +$25.6K ﹤0.01% 3100
2013
Q3 		$15K Buy
+7
New +$13K ﹤0.01% 3111

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Nationwide Fund Advisors's HSTO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q4 2017, closing a stake of 73 shares — an estimated $80K sold.

Nationwide Fund Advisors first reported a position in HSTO in Q3 2013 and held it in 6 quarters. The position peaked at $413K in Q1 2017. 70 funds tracked by Wall St. Rank hold HSTO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Histogen Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 73 Histogen Inc. Common Stock shares in Q4 2017, an estimated $80K.
  • Nationwide Fund Advisors first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 6 quarters.
  • Nationwide Fund Advisors's Histogen Inc. Common Stock position peaked at $413K in Q1 2017.
  • 70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.